Related Experiment Video
Updated: Jul 6, 2026
Routine Screening Method for Microparticles in Platelet Transfusions
Published on: January 31, 2018
Automatic detection of immature platelets for decision making regarding platelet transfusion indications for
Katsuyasu Saigo1, Yasuyuki Sakota, Yukako Masuda
1Blood Transfusion Division, Kobe University Hospital, Chuo-ku, Kobe 650-0017, Japan. saigo@med.kobe-u.ac.jp
Insights
Immature platelet fraction (IPF) indicates thrombopoiesis. Detecting IPF using a hematology analyzer can predict imminent platelet recovery in pediatric cancer patients, potentially avoiding unnecessary platelet transfusions.
Area of Science:
- Hematology
- Oncology
- Clinical Pathology
Background:
- Immature or reticulated platelets are key indicators of thrombopoiesis.
- Automated detection of immature platelet fraction (IPF) is now feasible with advanced hematology analyzers.
Purpose of the Study:
- To evaluate the utility of IPF detection in pediatric patients undergoing chemotherapy for malignant disorders.
- To determine if IPF can serve as a marker for predicting platelet recovery.
Main Methods:
- Analysis of immature platelet fraction (IPF) levels in 16 pediatric patients with various malignant disorders.
- Utilized the XE-2100 hematology analyzer for automated IPF detection.
Main Results:
- IPF levels were monitored in pediatric cancer patients post-chemotherapy.
- Results suggest IPF is a reliable indicator of impending platelet count recovery.
Conclusions:
- Immature platelet fraction (IPF) is a valuable biomarker for predicting platelet recovery.
- IPF monitoring may help optimize platelet transfusion strategies, reducing unnecessary interventions.
Abstract:
Immature or reticulated platelets are known as a clinical marker of thrombopoiesis. Recently, an automatic method was established to detect reticulated platelets as immature platelet fraction (IPF) by means of hematology analyzer XE-2100. We assessed the effects of IPF detection after chemotherapy for various pediatric malignant disorders of 16 patients. Our results indicate that IPF should be considered a useful marker of imminent platelet recovery so that unnecessary platelet transfusion can be avoided.
